Tweet
ModernMedicine
<img alt="" height="1" width="1" />
Denosumab Slows Bone Events in Prostate CA
MedPage Today
Note that bone metastases are a major burden in men with advanced prostate cancer, and agents are being evaluated to determine if they can delay skeletal-related events in this population. ...
Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab ...Bradenton Herald
Newer Drug May Help Prevent Fracture in Men With Prostate CancerU.S. News & World Report
Denosumab May Delay Skeletal-Related EventsDoctors Lounge
Medical News Today (press release) -Curetoday.com (press release)
all 11 news articles »
More...